125 related articles for article (PubMed ID: 15829433)
1. Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression.
Scrivens M; Dickenson JM
Pharmacol Res; 2005 Jun; 51(6):533-8. PubMed ID: 15829433
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of the P2Y14 receptor in human neutrophils.
Scrivens M; Dickenson JM
Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of the P2Y14 receptor in murine T-lymphocytes.
Scrivens M; Dickenson JM
Br J Pharmacol; 2005 Oct; 146(3):435-44. PubMed ID: 15997228
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor.
Carter RL; Fricks IP; Barrett MO; Burianek LE; Zhou Y; Ko H; Das A; Jacobson KA; Lazarowski ER; Harden TK
Mol Pharmacol; 2009 Dec; 76(6):1341-8. PubMed ID: 19759354
[TBL] [Abstract][Full Text] [Related]
5. The P2Y14 receptor of airway epithelial cells: coupling to intracellular Ca2+ and IL-8 secretion.
Müller T; Bayer H; Myrtek D; Ferrari D; Sorichter S; Ziegenhagen MW; Zissel G; Virchow JC; Luttmann W; Norgauer J; Di Virgilio F; Idzko M
Am J Respir Cell Mol Biol; 2005 Dec; 33(6):601-9. PubMed ID: 16109883
[TBL] [Abstract][Full Text] [Related]
6. UDP-sugars activate P2Y
Abbas ZSB; Latif ML; Dovlatova N; Fox SC; Heptinstall S; Dunn WR; Ralevic V
Vascul Pharmacol; 2018 Apr; 103-105():36-46. PubMed ID: 29253618
[TBL] [Abstract][Full Text] [Related]
7. Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems.
Fricks IP; Carter RL; Lazarowski ER; Harden TK
J Pharmacol Exp Ther; 2009 Jul; 330(1):162-8. PubMed ID: 19339661
[TBL] [Abstract][Full Text] [Related]
8. Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose.
Skelton L; Cooper M; Murphy M; Platt A
J Immunol; 2003 Aug; 171(4):1941-9. PubMed ID: 12902497
[TBL] [Abstract][Full Text] [Related]
9. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK
Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514
[TBL] [Abstract][Full Text] [Related]
10. UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms.
Bassil AK; Bourdu S; Townson KA; Wheeldon A; Jarvie EM; Zebda N; Abuin A; Grau E; Livi GP; Punter L; Latcham J; Grimes AM; Hurp DP; Downham KM; Sanger GJ; Winchester WJ; Morrison AD; Moore GB
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G923-30. PubMed ID: 19164486
[TBL] [Abstract][Full Text] [Related]
11. Role of UDP-Sugar Receptor P2Y
Mikolajewicz N; Komarova SV
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326617
[TBL] [Abstract][Full Text] [Related]
12. Novel vasocontractile role of the P2Y₁₄ receptor: characterization of its signalling in porcine isolated pancreatic arteries.
Alsaqati M; Latif ML; Chan SL; Ralevic V
Br J Pharmacol; 2014 Feb; 171(3):701-13. PubMed ID: 24138077
[TBL] [Abstract][Full Text] [Related]
13. Is GPR17 a P2Y/leukotriene receptor? examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17.
Qi AD; Harden TK; Nicholas RA
J Pharmacol Exp Ther; 2013 Oct; 347(1):38-46. PubMed ID: 23908386
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the contractile P2Y14 receptor in mouse coronary and cerebral arteries.
Haanes KA; Edvinsson L
FEBS Lett; 2014 Aug; 588(17):2936-43. PubMed ID: 24911208
[TBL] [Abstract][Full Text] [Related]
15. UDP-glucose, a cellular danger signal, and nucleotide receptor P2Y14 enhance the invasion of human extravillous trophoblast cells.
Katakura S; Takao T; Arase T; Yoshimasa Y; Tomisato S; Uchida S; Masuda H; Uchida H; Tanaka M; Maruyama T
Placenta; 2020 Nov; 101():194-203. PubMed ID: 33011563
[TBL] [Abstract][Full Text] [Related]
16. UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation.
Gao ZG; Ding Y; Jacobson KA
Biochem Pharmacol; 2010 Mar; 79(6):873-9. PubMed ID: 19896471
[TBL] [Abstract][Full Text] [Related]
17. Identification of a carbohydrate recognition motif of purinergic receptors.
Zhao L; Wei F; He X; Dai A; Yang D; Jiang H; Wen L; Cheng X
Elife; 2023 Nov; 12():. PubMed ID: 37955640
[TBL] [Abstract][Full Text] [Related]
18. Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.
Lee SA; Park JH; Lee SY
Mol Cells; 2013 Sep; 36(3):273-7. PubMed ID: 24048691
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.
Abbracchio MP; Boeynaems JM; Barnard EA; Boyer JL; Kennedy C; Miras-Portugal MT; King BF; Gachet C; Jacobson KA; Weisman GA; Burnstock G
Trends Pharmacol Sci; 2003 Feb; 24(2):52-5. PubMed ID: 12559763
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of UDP-glucose on cAMP generation and insulin secretion.
Parandeh F; Amisten S; Verma G; Mohammed Al-Amily I; Dunér P; Salehi A
J Biol Chem; 2020 Nov; 295(45):15245-15252. PubMed ID: 32855238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
